Highly portable quantitative screening test for prostate-specific antigen at point of care

Prostate cancer (PCa) is the second most diagnosed cancer among men. Targeted PCa screening may decrease PCa-specific mortality. Prostate-specific antigen (PSA) is the most reliable and widely accepted tumor biomarker for screening and monitoring PCa status. However, in many settings, quantification...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Balaji, Nanus, David M., Erickson, David, Mehta, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789004/
https://www.ncbi.nlm.nih.gov/pubmed/35083431
http://dx.doi.org/10.1016/j.crbiot.2021.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789004/
https://www.ncbi.nlm.nih.gov/pubmed/35083431
http://dx.doi.org/10.1016/j.crbiot.2021.11.003

Ejemplares similares